Zithromax & Zoloft

With $20 billion in free cash reserves, the company certainly possesses the resources vital to remain alive and kicking even after this particularly huge setback, but consider this – it is currently faced with the titanic wall of financial erosion with its sales for its two other important drugs – Zithromax & Zoloft – also being hit by patent expirations. Jeffrey B. Kindler, CEO, Pfizer, does sound positive as he proclaims, “We understand the challenge that this represents and we will respond quickly and aggressively to it...”, but isn’t it also true that company officials had falsely announced that all’s well with the tests, just a few days before the heartbreaking announcement?

For Complete IIPM Article, Click on IIPM Article

Source : IIPM Editorial, 2006

An IIPM and Management Guru Professor Arindam Chaudhuri's Initiative